Worm Margitta, Cichocka-Jarosz Ewa, Ruëff Franziska, Spindler Thomas, Köhli Alice, Trück Johannes, Lange Lars, Hartmann Karin, Hawranek Thomas, Nemat Katja, Pföhler Claudia, Bilò Maria Beatrice, Sabouraud-Leclerc Dominique, Wagner Nicola, Papadopoulos Nikolaos, Hämmerling Susanne, Ensina Luis Felipe, Dölle-Bierke Sabine, Höfer Veronika
Division of Allergy and Immunology, Department of Dermatology, Venereology, and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Department of Paediatrics, Jagiellonian University Medical College, Krakow, Poland.
J Allergy Clin Immunol Pract. 2025 Jan;13(1):69-78.e2. doi: 10.1016/j.jaip.2024.08.036. Epub 2024 Aug 28.
Hymenoptera venom is one of the most frequent causes of anaphylaxis. Studies from adults indicate the clinical profiles and risk factors of Hymenoptera venom-induced anaphylaxis (VIA). Much less is known about pediatric VIA.
To understand elicitor- and age-related factors determining pediatric VIA by analyzing data from the anaphylaxis registry.
We selected pediatric VIA, pediatric food-induced anaphylaxis (FIA), and adult VIA cohorts from the anaphylaxis registry and performed a comparative data analysis regarding elicitors, symptoms, and management.
We identified 725 pediatric patients with VIA, 3,149 with pediatric FIA, and 5,534 with adult VIA. In pediatric VIA, boys were more frequently affected, atopy was not increased, and the onset of the reaction after exposure was fast (≤30 min; 91%) compared with pediatric FIA. Symptoms in pediatric VIA were age dependent, and although respiratory symptoms occurred most frequently besides skin symptoms in both pediatric patients with VIA and FIA, cardiovascular symptoms were more frequently reported in pediatric patients with VIA than pediatric patients with FIA. The analysis of pediatric versus adult VIA revealed clear differences in the frequency of involved organ systems (skin: 93% vs 78%; respiratory: 77% vs 64%; and cardiovascular: 61% vs 85%). For both pediatric and adult VIA, the rates of adrenaline application by a professional were low (29% vs 31%) but hospitalization rates were higher in children than in adults (61% vs 42%). Venom immunotherapy was frequently initiated regardless of age (78% each).
Pediatric VIA is more frequent in boys, symptoms are age dependent, and hospitalization is often required. Adrenaline should be applied according to current guidelines. Venom immunotherapy is an important treatment option in pediatric VIA and should be considered in severely affected children.
膜翅目昆虫毒液是过敏反应最常见的诱因之一。针对成人的研究表明了膜翅目昆虫毒液诱发过敏反应(VIA)的临床特征和风险因素。而关于儿童VIA的了解则少得多。
通过分析过敏反应登记处的数据,了解决定儿童VIA的诱发因素和年龄相关因素。
我们从过敏反应登记处选取了儿童VIA、儿童食物诱发过敏反应(FIA)和成人VIA队列,并对诱发因素、症状和处理方式进行了对比数据分析。
我们确定了725例儿童VIA患者、3149例儿童FIA患者和5534例成人VIA患者。在儿童VIA中,男孩受影响更为频繁,特应性并未增加,与儿童FIA相比,接触后反应发作迅速(≤30分钟;91%)。儿童VIA的症状与年龄有关,尽管在儿童VIA和FIA患者中,除皮肤症状外,呼吸道症状最为常见,但儿童VIA患者报告的心血管症状比儿童FIA患者更频繁。儿童与成人VIA的分析显示,受累器官系统的频率存在明显差异(皮肤:93%对78%;呼吸道:77%对64%;心血管:61%对85%)。对于儿童和成人VIA,专业人员使用肾上腺素的比例都较低(29%对31%),但儿童的住院率高于成人(61%对42%)。无论年龄大小,毒液免疫治疗的启动频率都很高(均为78%)。
儿童VIA在男孩中更为常见,症状与年龄有关,且常需住院治疗。应根据现行指南应用肾上腺素。毒液免疫治疗是儿童VIA的重要治疗选择,对于重症患儿应予以考虑。